Get the Stockscreener App
4.77
0.21%
0.010
After Hours:
4.67
-0.10
-2.10%
Rallybio Corp stock is traded at $4.77, with a volume of 21,402.
It is up +0.21% in the last 24 hours and down -17.87% over the past month.
Rallybio Corp is a clinical-stage biotechnology company engaged in the development of therapeutic candidates for severe and rare diseases. It focuses on the treatment of conditions related to complement dysregulation and hematologic disorders. The company's flagship program, RLYB116, is a C5 inhibitor being evaluated for potential use in diseases associated with complement dysregulation, including immune platelet transfusion refractoriness and refractory antiphospholipid syndrome. Its pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody candidate under investigation for the treatment of iron overload disorders.
See More
Previous Close:
$4.76
Open:
$4.7
24h Volume:
21,402
Relative Volume:
0.95
Market Cap:
$25.19M
Revenue:
-
Net Income/Loss:
$-74.56M
P/E Ratio:
-2.6043
EPS:
-1.8316
Net Cash Flow:
$-60.27M
1W Performance:
+2.55%
1M Performance:
-17.87%
6M Performance:
+18.37%
1Y Performance:
-17.76%
1-Day Range:
$4.70
$4.89
1-Week Range:
$4.41
$5.37
52-Week Range:
$1.7608
$6.7496
Rallybio Corp Stock (RLYB) Company Profile
Name
Rallybio Corp
Sector
Industry
Phone
203- 859-3820
Address
234 CHURCH STREET, NEW HAVEN
Compare RLYB vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
4.77 | 25.14M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-15-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-07-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-17-23 | Initiated | H.C. Wainwright | Buy |
| Apr-10-23 | Initiated | Wedbush | Outperform |
| Dec-09-22 | Initiated | JP Morgan | Overweight |
| Feb-22-22 | Initiated | JMP Securities | Mkt Outperform |
| Aug-23-21 | Initiated | Cowen | Outperform |
| Aug-23-21 | Initiated | Evercore ISI | Outperform |
| Aug-23-21 | Initiated | Jefferies | Buy |
View All
Rallybio Corp Stock (RLYB) Latest News
Rallybio’s Strategic Pivot: A Focused Path Forward - AD HOC NEWS
Gainers Report: Is Rallybio Corporation forming higher highs and higher lows2025 Buyback Activity & Fast Momentum Entry Tips - baoquankhu1.vn
Bank Watch: Is Rallybio Corporation stock trending bullish2025 Buyback Activity & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Is Rallybio Corporation stock trending bullishTrade Exit Summary & Detailed Earnings Play Strategies - baoquankhu1.vn
Rallybio Corporation (NASDAQ:RLYB) Receives $5.00 Average Price Target from Brokerages - Defense World
Portfolio Shifts: Is Rallybio Corporation subject to activist investor interest2025 Stock Rankings & Accurate Buy Signal Alerts - baoquankhu1.vn
Rallybio To Implement 1 For 8 Reverse Stock Split To Regain Nasdaq Compliance;Stock Down - Nasdaq
Rallybio announces reverse 1-for-8 stock split - TipRanks
Rallybio announces one-for-eight reverse stock split effective Feb 6 - Investing.com Nigeria
Rallybio Announces Reverse Stock Split of Common Stock - PharmiWeb.com
Rallybio reverse split swaps 8 shares for 1, cash for fractions - Stock Titan
Rallybio announces one-for-eight reverse stock split effective Feb 6 By Investing.com - Investing.com South Africa
Growth Review: Is Rallybio Corporation subject to activist investor interestRecession Risk & AI Driven Stock Price Forecasts - baoquankhu1.vn
Market Fear: Does Rallybio Corporation stock benefit from AI growthChart Signals & Community Consensus Trade Alerts - baoquankhu1.vn
Rallybio to implement 1-for-8 reverse stock split effective February 6 By Investing.com - Investing.com Nigeria
Rallybio to implement 1-for-8 reverse stock split effective February 6 - Investing.com
Rallybio Shareholders Approve Reverse Stock Split Amendment - TipRanks
Value Recap: What is the long term forecast for Tanger Inc stockJuly 2025 Review & Weekly Momentum Picks - baoquankhu1.vn
Market Pulse: What is Rallybio Corporations valuation compared to sectorJuly 2025 Big Picture & Expert Verified Stock Movement Alerts - baoquankhu1.vn
RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks - MSN
Aug Momentum: Whats the profit margin of Rallybio CorporationPortfolio Gains Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Biotech Update: IFRX, ABCL, RLYB Stand Out as Significant Gainers After Hours - Intellectia AI
Brokerages Set Rallybio Corporation (NASDAQ:RLYB) PT at $5.00 - Defense World
Rallybio Terminates Phase 2 FNAIT Pregnancy Study: What Investors Need to Know - TipRanks
Why analysts upgrade Rallybio Corporation stockQuarterly Performance Summary & Entry and Exit Point Strategies - Улправда
Will Rallybio Corporation stock deliver shareholder valueRisk Management & Community Consensus Trade Alerts - Улправда
Rallybio’s Phase 2 FNAIT Prevention Study Reaches Completion: What Investors Should Watch Next - TipRanks
Why Rallybio Corporation stock is a value investor pickSeasonal Picks & HOKA buying tips before checkout - Улправда
What margin trends mean for Rallybio Corporation stockJuly 2025 Outlook & Reliable Price Action Trade Plans - Улправда
Is Rallybio Corporation stock a buy in volatile markets2025 Volume Leaders & Verified Chart Pattern Trade Signals - Улправда
How Rallybio Corporation stock reacts to oil pricesStock Surge & Safe Capital Growth Trade Ideas - Улправда
Is Rallybio Corporation stock resilient to inflationProfit Target & Risk Controlled Daily Plans - Улправда
Aug Sentiment: What margin trends mean for Rallybio Corporation stockJuly 2025 Outlook & Reliable Price Action Trade Plans - ulpravda.ru
Rallybio (NASDAQ:RLYB) Trading Up 5.4% – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Rallybio seeks reverse stock split to maintain Nasdaq listing - Hartford Business Journal
US Market Wrap: Why Rallybio Corporation stock is a value investor pickJuly 2025 Price Swings & High Accuracy Trade Alerts - moha.gov.vn
Will Rallybio Corporation stock outperform Dow Jones index2025 Market Overview & Daily Market Momentum Tracking - Улправда
Jobs Data: Can Rallybio Corporation stock double in next 5 yearsEarnings Risk Summary & Fast Moving Trade Plans - Улправда
How risky is Rallybio Corporation stock nowQuarterly Market Review & Growth Focused Stock Reports - DonanımHaber
Can Rallybio Corporation stock double in next 5 yearsPortfolio Growth Summary & Weekly Watchlist of Top Performers - Улправда
Rallybio (NASDAQ:RLYB) Stock Price Up 5.1% – Still a Buy? - Defense World
Breakouts Watch: Why Rallybio Corporation stock could outperform in 2025July 2025 Review & Consistent Profit Focused Trading Strategies - moha.gov.vn
Will Rallybio Corporation stock deliver consistent dividendsBull Run & Growth-Oriented Investment Plans - Newser
Will Rallybio Corporation stock split attract more investorsPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - Newser
Is Rallybio Corporation stock attractive for passive investorsTrade Volume Summary & Short-Term High Return Ideas - Newser
Rallybio Corp Stock (RLYB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):